Re-reading my post, I concede that it could have been taken that way and I should have worded my first statement differently.
My point though, was that the fact that it's "novel", from an approval perspective, doesn't in any way translate to it necessarily being a more safe/effective treatment or "game-changing".
BOT Price at posting:
41.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)